
What We're Reading: Eliminating Cost Sharing for Insulin; Economic Projections Scrapped; Returning to Work Recommendations
A bill introduced yesterday by Representative Maxine Waters, with support from the American Diabetes Association, would eliminate cost sharing for patients with diabetes requiring insulin amid the coronavirus disease 2019 pandemic; White House officials have decided to not release economic projections this summer for the first time since the 1970s; CDC provides recommendations for employers returning to the workplace.
Bill Seeks to Eliminate Cost Sharing for Insulin
Representative Maxine Waters, D-California, with support from the American Diabetes Association (ADA), introduced a bill yesterday that would allow all insulin-dependent Medicare beneficiaries to obtain their prescriptions for insulin and related medical supplies with no co-payment, coinsurance, deductibles, or other cost sharing for the remainder of the coronavirus disease 2019 (COVID-19) pandemic. Noted in a
White House Will Not Release Economic Projections This Summer
In an unprecedented move, White House officials have decided to not release updated economic projections this summer, which would highlight the severe economic decline caused by the COVID-19 pandemic. Reported by
CDC Provides Office Recommendations for Returning Employers
The CDC provided
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.